{
    "title": "US is buying 5 billion dollars of Pfizer COVID pills (10 million dollars of Vitamin D might do as well)",
    "slug": "us-is-buying-5-billion-dollars-of-pfizer-covid-pills-10-million-dollars-of-vitam-ight-do-as-well",
    "aliases": [
        "/US+is+buying+5+billion+dollars+of+Pfizer+COVID+pills+10+million+dollars+of+Vitamin+D+might+do+as+well+-+Nov+2021",
        "/13088"
    ],
    "tiki_page_id": 13088,
    "date": "2021-11-16",
    "categories": [
        "Virus"
    ],
    "tags": [
        "Virus",
        "influenza",
        "pfizer",
        "virus",
        "vitamin d",
        "vitamin d and viruses"
    ]
}


{{< toc >}}

---

#### Update Nov 27, 2021: Molnupiravir only reduces risk by 30%, not 50%

 **[New data shows Merck’s experimental covid-19 pill is less effective than early results predicted](https://www.washingtonpost.com/health/2021/11/26/fda-merck-antiviral-pill/?utm_campaign=wp_post_most&utm_medium=email&utm_source=newsletter&wpisrc=nl_most&carta-url=https%3A%2F%2Fs2.washingtonpost.com%2Fcar-ln-tr%2F3562a95%2F61a264d89d2fdab56ba3ad29%2F596bdb5f9bbc0f403f990f33%2F11%2F70%2F61a264d89d2fdab56ba3ad29)** 

* "But according to the latest findings Merck presented to the FDA, the pill reduced the risk of hospitalization and death only by 30 percent."

---

#### [The U.S. plans to buy enough of Pfizer’s Covid antiviral pills for 10 million people](https://www.nytimes.com/2021/11/16/us/politics/biden-pfizer-covid-pill-purchase.html)

 **New York Times - Nov 16, 2021** 

* 30 pills to be taken within 5 days of the first sign of COVID-19 symptoms_

* "The Biden administration is planning to pay more than five billion dollars for a stockpile of [Pfizer’s new Covid-19 pill](https://www.nytimes.com/2021/11/16/business/pfizer-covid-pill-paxlovid-unvaccinated.html), enough for about  **10 million courses of treatment** , after the company gears up production next year, according to people familiar with the agreement."

* The government has also ordered [3.1 million treatment courses, with options for 2 million more, of Merck’s pill,](https://www.merck.com/news/merck-and-ridgeback-announce-u-s-government-to-purchase-1-4-million-additional-courses-of-molnupiravir-an-investigational-oral-antiviral-medicine-for-the-treatment-of-mild-to-moderate-covid-19-in-a/) at about  **$700 per person.** 

*  **[PFizer Press Release](https://www.pfizer.com/news/press-release/press-release-detail/pfizers-novel-covid-19-oral-antiviral-treatment-candidate) Nov 7, 2021** 

*  **[Outcome of 1 COVID-19 paxlovid study](https://c19early.com/plmeta.html) 85% reduction in hospitalization** 

   * [summary of Press Release](https://c19early.com/pfizerpaxlovid.html) from c19early.com/

---

#### Early Treatment Options Compared

| | | | |
| --- | --- | --- | --- |
|  | Vitamin D<br>>100 companies | Molnupiravir <br>Merck - patented | Paxlovid<br>Pfizer - patented |
| Cost per treatment | $1 | $700 | <$700 |
| Experience<br>with medication | >100,000,000 people<br>over 70 years | 400 people in an RCT<br> over a few months | 1200 people<br>1 month |
| COVID studies<br>of the treatment | >100 peer reviewed | no peer review | [Press Release](https://www.pfizer.com/news/press-release/press-release-detail/pfizers-novel-covid-19-oral-antiviral-treatment-candidate)  |
| Reduced risk <br>of hospitalization | >2X perhaps 8X  | 2X | 6X |
| Vaccinated? | does not matter | trial participants <br>were UNvaccinated | trial participants <br>were UNvaccinated |
| Health problems <br>Treated | COVID-19, colds, flu <br> coronavirus, +((Proof that Vitamin D Works | 64 others)) | COVID-19 | COVID-19 |
| Health problems<br>Prevented | with periodic dosing<br> ((Proof that Vitamin D Works | 26 health problems))  | none | none  |